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Characterisation of Na/K-ATPase, its isoforms, and 
the inotropic response to ouabain in isolated failing 
human hearts 
Olga I Shamraj, Ingrid L Grupp, Gunther Grupp, David Melvin, Nathalie Gradoux, 
Walter Kremers, Jerry B Lingrel, and Alain De Pover 
Objective: The aim was to determine whether failing human hearts have increased sensitivity to the inotropic 
and toxic effects of ouabain, and to examine alterations in NdK-ATPase that might explain the observed higher 
ouabain sensitivity. Methods: For contractility studies, a total of 57 trabeculae were isolated from two non- 
failing (death from head injury) and 10 terminally failing, explanted human hearts. After the experiment, each 
trabecula was inspected under the light microscope for morphological alterations consistent with heart failure. 
Samples for biochemical and molecular studies were obtained from five non-failing and 13 failing hearts. Total 
NdK-ATPase was measured in desoxycholate treated homogenates and expressed per unit of tissue wet or dry 
weight, DNA, protein, or myosin. Interference from residual bound digoxin due to previous therapy was 
excluded. The expression of the three ci isoforms was studied at both the mRNA level using northern blots and 
the protein level by analysis of dissociation kinetics of the [3H]ouabain-enzyme complex. Results: Trabeculae 
showing morphological alterations and decreased contractility were sensitive to lower concentrations of ouabain 
(3-100 nM) than control trabeculae (100-1000 nM); the inotropic ECSo and the minimum toxic concentration 
were both reduced. [3H]Ouabain binding was significantly lower (p<<O.OOl) in failing than in non-failing hearts, 
at 293(SD 74) v 507(48) p m o l g '  wet weight. No significant change was observed in maximum ATPase turnover 
rate, or in sensitivities to Na+, K', vanadate, and dihydro-ouabain. All three ci isoforms were expressed at the 
mRNA level in both normal and failing hearts. Conclusions: This study shows conclusively, for the first time, 
that failing human hearts are more sensitive to ouabain. This may be at least partly due to a mean reduction 
of 42% (95% confidence interval, 26 to 56%) in the concentration of NdK-ATPase (decrease in Na,K pump 
reserve), but not to an alteration in its catalytic properties or in its isoform composition. 
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ardiac glycosides have been widely used in the 
treatment of congestive heart failure. Their basic C mechanism of action consists in inhibiting N d  
K-ATPase, which leads to a rise in intracellular free Na' 
concentration and, through alteration of NdCa exchange, to 
the enhancement of Ca2+ transients and of cardiac con- 
traction.' However, excessive inhibition induces Ca" over- 
load, causing arrhythmia, a decrease in developed tension, 
and contracture.2 Although it is known that patients with 
advanced heart disease are more susceptible to glycoside 
induced  arrhythmia^,^ the direct effect of the drugs on the 
diseased myocardium is still poorly documented. While one 
study has shown that papillary muscle strips isolated from 
terminally failing hearts responded to the inotropic action of 
ouabain at lower concentrations than strips from non-failing 
hearts, the interpretation of this difference was complicated 
by the fact that the inotropic action showed an all or nothing 
effect in non-failing hearts instead of a typical concentration 
dependent response, and also by the absence of arrhythmia 
data.4 In biochemical studies, it is still uncertain for 
methodological and statistical reasons whether the density of 
the glycoside receptor, the NdK-ATPase, on the cadiac cell 
membrane decreases, and if so to what e ~ t e n t . ~  (This point 
will be discussed in detail below.) Furthermore, the catalytic 
properties of NdK-ATPase have not yet been studied in 
diseased human hearts, and although the expression of three 
ci isoforms at the mRNA level has been reported,67 no 
information is available at the protein level. 
In the present study on NdK-ATPase, contractility 
experiments revealed a population of failing heart trabeculae 
with increased sensitivity to the inotropic and toxic effects 
of ouabain. In these experiments, concentration dependent 
inotropic effects were obtained with both failing and non- 
failing hearts, allowing quantitative comparison. The recent 
availability of relatively large samples of human heart from 
patients undergoing cardiac transplantation has made it 
possible to undertake a comprehensive study of Nd 
K-ATPase properties. Thus we decided to test different 
hypotheses that could account for the increased ouabain 
sensitivity: (1) a switch in isoform gene expression, (2) a 
decreased density of ouabain binding sites, (3) reduced Nd 
K-ATPase turnover rate, and (4) reduced Na' sensitivity. For 
this study to be valid, it was critical to demonstrate the 
complete recovery of NdK-ATPase from tissue samples, the 
independence of the results from the reference used to 
express the data (for example, tissue wet weight), and the 
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absence of interference from residual bound digoxin 
resulting from drug therdpy prior to surgery. Some of the 
discrepancies reported i n  previous studies of NdK-ATPase 
in human heart may be explained by the fact that these 
variables were not considered, as well as by the differences 
in the methods used. The present results support the 
hypothesis that a decrease in  NdK-ATPase density underlies 
the greater sensitivity of severely failing hearts to cardiac 
glycosides. These investigations were approved by the local 
ethics review committees. Preliniinary results have been 
reported.h ' 
Methods 
Contrii(.tili!J \ r i d \  
'irabeculat bere taken from erplanted hearts ohtained in collaboration 
with the Gni\ ersity of Cincinnati cardiac transplantation programme. 
Failinp he;irt\ carried the general pathological diagnoses of ischaemic, 
h> pi'rtrophic. or dilated cardiomyopathy. Non-failing hearts (death from 
head inlur! ) iwild not be implanted for technical reasons. The hearts 
were placed i n  ice cold Krebs-Henseleit solution in the operating theatre 
immediately alicr removal. The mural trabeculae were excised from the 
walls of  both right and left atria and ventricles and stored for a short 
time on ice hefhrc being mounted and suspended in a 70 ml assay bath 
at 35°C. We chose traheculae 1 mni wide and 5 nun long. No Purkinje 
tihres o r  \ isiblq necrotic tihres were used. Contractility measurements 
were performed as pre\ ioualy described."' BrieHy. the trabeculae were 
placed in a muscle holder in contact with two pointed platinum 
electrodes used for stiniulation. connected to a force transducer (Gra\s 
i+T 03C). and studied under isometric conditions: initially they were 
stretched t o  ii length at which Force was maximal (L,,,,). The 
stimulntion rate wab 1.0 Hr. 2 to 5 ms duration, with a voltage 204 
above threshold. Contractile force and its first derivative dF/dt were 
recorded on ;I Crass P7 polygraph. After eyuilihration for 60 min, 
cuniulative ouabain dose-response curves were obtained by adding 
iiuabain in increasing concentrations from 1 to 1000 nM every 40-60 
min. The duration of exposure was long enough to bring the traheculae 
close to their maximum response at each concentration. When clear 
s i p  of toxicity became apparent (increase in resting tension. decrease 
in active tension. irregularities in  contractility and/or contracture) the 
experiment m a \  terminated. 
Iic wc m~qi~i.\iiio~i f i l r northeix uiiuly\i,s tinil hinc heriiicol sriidit~s 
B e d e s  the heart sample\ used above for contractility studies. samples 
from additional hearts were procured over a later time period for RNA 
isolation and biochemical studies. Samples from three failing and I3 
nori-Faiiinp hertrts were collected in conjunction with the University of 
Cincinnati cardiac transplantation programme. Samples from two 
normal hearts that were wed for biochemical studie\ only were supplied 
hy thc International Institute tor the Advancement of Medicine 
tEs\ington. PA, L!SA). The material included end stage failing hearts 
froin patient\ with diagnoses of ischaemic. idiopathic, idiopathic 
dilated, dilated. hypertensive. or hypertrophic cardioniyopathy. and 
nowfailing hearts (death twin head injury) that could not be implanted 
for technical reamns. All patients with heart failure had undergone left 
and right heart carheterisation. echocardiography. and multiple gated 
iiucleiir an~iocardiograpliic scanning. Mean right atrial pressure and 
mean pulnionary arterial pressure were recorded from fluid filled 
preshurc transducers zeroed at mid-axillary level in the supine position. 
Cardiac output IKIS determined by thermodilution. using right atrial 
in-jection and ii pulmonary arterial catheter tip thermistor. Left 
ventricular ejection fraction was determined from the ratio of 
radioisotopic acti\it) at end systole to that in end diastole in the left 
ventriculai- profile ;it nuclear angiocardiography. Clinical data are 
wnimarised in table 11. The principal therapy prior to cardiac 
transplantation had been diuretics and converting enzyme inhibitors: 
five patients had ~ilw been receiving digoxin. On explantation, samples 
from each heart were imniediatelg frozen in liquid nitrogen and stored 
31 -70°C. 
~~'~ll~therll  f i l l  " I  r,\r.> 
Total cellular R K A  was iwlated from tissue samples and northern blot 
anal\ise\ carried out as described.' ' I  Data obtained from three non- 
failing hearts in the present study have already been reportedb and are 
shown for comparison onl) (f ig I A ) .  Brietly. 10 ~g of total RNA was 
iaolated and fractionated o n  agarose gels and transferred to nylon 
inembrrtnes (hilngna NT. MSI) .  Total RNA from both the left and right 
ventricles ut' 13 diwn\ed hcarts was used to make two sets of three 
identical blot\. Each set wa\ hyhridised with ul .  u2. and a3 specific 
6Omer oligonucleotide probes (described in detail in ') and end labelled 
to a uniform specific activity with (y"P)-ATP (3000 Ci.mniol-'. New 
England Nuclear). Northern blots were exposed to x ray film for 
autoradiograph) and to :i Pho\phor screen for quantification with a 
Figure 1 Northern blot anal~~sis  of' NdK-ATPuse a isofr~rrri 
inRNA expression iii hiitnun heart. Each lane contains 10 pg oj 
total celliilur RNA isoluted from human control tissues (kidnej ( K ) ,  
skeletul muscle (S). und bruin ( B ) )  wid f rom left unrl right 
wntriciilar free wall ( L  and R, respectively) ,froin three non$uilin~ 
himuti hearts (punel A ,  henrts I ,  2, and 3)6 and from 13 disea.sed 
Iieurts (panels B mid C, lzearts 4-16). The clussiJication of the 
diseased hetrrts Liccording the type of curdiomyopathy was u s  
,follo~.s: jive ischueniic (hearts 5, 7. 9, 10, and I S ) ,  three idiopathic 
(helirts 8, 13, 16), one dilated (heart 41, two idiopathic diluted 
(hearts 11, 12), one hypertensive (heart 14), and one hypertrophic 
(heart 6).  Blots were probed with al ,  a2, and a3 isoform-specific 
"P tubelled probes ttnd exposed to x ruy ,film ,[or j ive  dtrys, then 
stripped tirid reprobed with N -j2P labelled 18s rRNA probe, which 
showed that ,some surnples were niore degrudrtl than other,s. 
Phosphorimager (Molecular Dynamics), then stripped and reprobed 
with a ."P labelled 18s rRNA 20rner. As controls, 10 pg of total RNA 
from human kidney (expresses a ] ) ,  skeletal muscle (expresses a I and 
a2). and brain (expresses u l .  a2. and a3) were included on each 
blot. 
Tissire liotnogenisatiori und detergent ireutment 
Pieces of frozen tissue were rapidly thawed in saline. Fat, vessels, and 
connective tissue were removed as well as possible with scissors. 
Unless otherwise stated. the following procedure was performed at 
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0-6°C. A sample weighing 0.5-2 g was minced and homogenised in 10 
ml of chilled buffer per g wet weight using a Polytron homogeniser, 
2 s at maximum setting, twice (buffer composition: 2 mM EDTA and 
10 mM Tris, pH adjusted to 7.4 with HCI). The homogenate was diluted 
to 30 ml with buffer and centrifuged at 100 000 g for 30 min. The pellet 
was homogenised in 6.5 ml buffer per g sample, with a Teflodglass 
Potter Elveljem homogeniser. Aliquots of these two homogenates were 
pooled and used for determinations of DNA, total protein, myosin, and 
creatine phosphokinase (CPK). The second homogenate was mixed 
with 3.5 ml (per g sample) of buffer supplemented with 2.86 mgm-I 
sodium desoxycholate (DOC). After 30 min incubation at room 
temperature, this mixture was frozen and kept overnight at -30°C. This 
treatment, used to permeabilise vesicles, revealed maximum latent N d  
K-ATPase activity (data not shown). After thawing, the mixture was 
centrifuged at 100 000 g for 2 h. The pellet was resuspended in 10 ml 
of buffer per g sample (buffer composition: 10 mM Tris, pH adjusted 
to 7.4 with HCl) and kept at -70°C until use. NdK-ATPase activity was 
stable for more than a year under these conditions. Four samples were 
processed per experimental run. No significant activity was found in the 
supernatants, indicating virtually complete recovery of the Na/ 
K-ATPase in the final suspension. In the following procedures, 
homogenates were stirred with vortex immediately before pipetting. 
Occaionally, minute fragments of non-homogenised tissue blocked the 
pipette tip and had to be removed. To avoid loss of material, no further 
attempt was made to remove unhomogenised tissue (for example, by 
low speed centrifugation or filtration), since we had observed that these 
procedures affected NdK-ATPase recovery differently in normal and 
diseased hearts. For all samples, NdK-ATPase activity and ['Hlouabain 
binding were assayed in two to three separate experiments. 
NdK-ATPase assay 
NdK-ATPase activity was determined by measuring inorganic 
phosphate (Pi) release from the ouabain sensitive hydrolysis of ATP by 
DOC treated homogenates as described." Protein (10-12 pg) was 
incubated for 60 min at 37°C in 0.1 mI medium containing (in 
mmo1,litre-') ATP 5, MgC1, 5, NaN' 5, NaCl 145, KCl 20, EGTA 1, 
and maleic acid 10 (pH adjusted to 7.4 with Tris). ATP hydrolysis never 
exceeded 20%. Basal activity was determined in the presence of 1 mM 
ouabain and represented about one third of total activity. Na/K-ATPase 
activity was linear with respect to time and protein concentration for 
all samples. Enzyme activation by Na' and K' was studied, according 
to the method of Skou," at a constant ionic strength by maintaining the 
total [Na' + K'] = 150 mM while the Na' and K' concentrations were 
varied. Na' was varied by increasing NaCl from 0 to 145 mM, while 
NaN3 remained constant at 5 mM. Maximum turnover rate was 
calculated from the ratio of maximum activity (V,J to maximum 
['Hlouabain binding (B,,,), assuming one ouabain binding site per 
catalytic subunit. Dihydro-ouabain inhibition curves were plotted at 5 
mM KC1. This glycoside was used instead of ouabain or digoxin 
because it binds quickly to NdK-ATPase. 
[3H]Ouabuin binding assay 
['HIOuabain binding to DOC treated homogenates was assayed by a 
filtration technique as des~ribed. '~ Briefly, 2.5-3 mg protein was 
incubated at 37°C in 5 ml medium containing (in mmo1,litre-I): MgCI, 
3, phosphoric acid 3, EGTA 1, and maleic acid 10 (pH adjusted to 7.4 
with Tris), plus 1 pM ['Hlouabain (3-6 Ci.mmol-', Amersham batch 
diluted with ouabain). Under these conditions, complete saturation of 
ouabain receptors was obtained (KD<O.O1 pM) and the specific binding 
represents B,,,. After 10 min incubation, 0.2 ml aliquots were filtered 
through Whatmann GFF glass fibre filters previously soaked in 0.3% 
polyethylenimine. Nonspecific binding was determined in the presence 
of 0.1 mM ouabain and did not exceed 10% of total binding. For 
['Hlouabain dissociation kinetics, 0.1 mM ouabain was added after the 
10 min incubation, and 0.2 ml aliquots were rapidly filtered at various 
times. 
Other biochemical assuys 
For DNA and creatine phosphokinase (CPK) determinations, sample 
aliquots were diluted in appropriate buffers and centrifuged for 2 min 
in an Eppendorf centrifuge. DNA was determined as describedI5 and 
CPK assayed using Boehringer Mannheim kits at 22-23°C. For total 
protein and myosin determinations, proteins were extracted with 2% 
SDS. Total protein was estimated by the bicinchoninic acid methodI6 
(reagents from Pearce, Rockford, Illjnois, US 4) and myosin levels were 
determined by densitometry after SDS electrophoresis according to 
Laemmli." Tissue dry weight was measured after freeze drying 0.2 ml 
of homogenate. 
Statistical analysis 
Clinical data were disclosed at the end of the study. The significance 
of observed differences between failing and non-failing hearts 
(unpaired) and between left and right ventricles (paired) was verified 
using appropriate t tests. F tests were used to check for differences 
linked with the aetiology of the disease (multiple groups). Differences 
were accepted as significant at the p<O.OS level. Unless otherwise 
indicated, data represent means(SD). In figs 3 and 4, SEM is shown 
instead of SD to make the graphs easier to read. 
Curve jtting analysis 
Lindenmayer and Schwartz have shown that NdK-ATPase activation 
by Na' and K' followed the relationship y = V,,,/(a,b.c), where the term 
a described the activation for three equivalent Na' sites and the terms 
b and c the activation for two non-equivalent K' sites.Ix Since the 
resolution of this equation requires a large number of experiments, to 
evaluate the two cations parsimoniously we replaced a and b.c by the 
logistic relationship, which is equivalent to the equation of Hill," 
leading to 
where y is the predicted effect, A the basal ATPase activity, BVa and 
BK the Hill coefficients, CNa and CK the concentrations for half 
maximum activity, D the maximum activity (V,,,,,), x the variable Na' 
concentration, and 150-x the variable K+ concentration. V,,,,, was 20% 
higher than the optimal activity measured at 130 mM Na' and 20 mM 
K'. The data fitted to this empirical function over a wide range of cation 
concentrations (fig 3). Note that although the above equation applies to 
the case where Na' and K' hind simultaneously, it does not rule out a 
sequential mechanism.'* 
NdK-ATPase inhibition curves were fitted to the logistic function" 
where y is the predicted effect, A the basal ATPase activity, B the Hill 
coefficient, C the concentration for half maximum inhibition, D the 
control specific activity, and x the variable concentration. 
['HIOuabain dissociation kinetics were fitted to the one site 
function" y = A  + D,e-klx or to the function for two independent sites'" 
y = A + D,e-kix + D2ck+ where y is the predicted effect, A the non- 
specific binding, k, and kz the first order dissociation rate constants, D 
the binding at 0 time, and x the variable time. 
For statistical analysis, curves were fitted by using individual sample 
or individual heart data whenever possible, and mean values and SD 
were calculated for groups of hearts. For ['Hlouabain kinetics, two site 
fit could not be performed with some samples because the binding was 
too low. In these cases, curves were fitted by using mean values of 
groups of hearts. 
Results 
Contractility 
In table I the inotropic responses to ouabain in trabeculae 
from non-failing and failing hearts are listed. The data from 
atrial and ventricular trabeculae were pooled, since there was 
no statistical difference between the chambers. The 
distinction between moderately and severely altered trabe- 
culae was made after the experiment, using a light 
microscope to evaluate the state of the myofibrils in the 
contraction bands, endocardia1 thickening, vacuolisation, 
scar formation, interstitial oedema, and mitochondria1 and 
nuclear damage. Seventeen trabeculae from seven explanted 
hearts were rated as moderately altered, and nine trabeculae 
from four hearts as severely altered. It is clear that minimal 
inotropic effects of ouabain occurred at 3 and 30 nM in the 
severely and moderately altered fibres compared to 100 nM 
in the normal ones. The ECsO and the minimal ouabain 
toxicity showed a similar relationship. In addition, the 
severely altered fibres responded with a significantly reduced 
maximum effect to both calcium (not shown) and ouabain. 
Trabeculae from two non-failing hearts served for 
comparison. 
NdK-ATPase Q isoform mRNA expression 
We have previously shown that all three a isofonns of N d  
K-ATPase mRNAs are expressed in normal human left and 
right ventricle (LV and RV, respectively) at high levels.6 
Northern blots of this result (fig 1A) are shown in this 
Nuniber of trabeculae 
arrial 
Ventricular 
total 
6 
I2  
18 ( 2  hearts) 
7 - 
1 1  
13 ( 5  heart\) 
I)e\ eloped tenwn (nip) 
at contiol 66% 1-10] 69 1 ( 133) 
'it ouabain ~ n a x i i n u ~ ~ i  inotrop> 1 8 0 0 ~ 5 1 3 )  1736(497) 
Ouabain inotropic re5poiise ( I ?  of maximuin j 
Concenrratioii cnM 1: 1 0 
0 
I 0 I 
-30 1 
100 29 
300 96 
1 O(X) I00 
0 
0 
I 
5 
24 
100 
98 
8 
9 
17 (7 hearts) 
568( 120) 
1425(416) 
0 
1 
2 
32 
92 
100 
- 
3 
6 
9 (4 hearts) 
554(129) 
732(273) 
2 
12 
2s 
60 
I00 
- 
- 
EC',. (nM) 1'326) 137122) 60(22) 34( 14) 
Minimum roxic   on cent ration ( n M )  10771 86) 1008(96) 376( 148) 144(50) 
Data froin atrial and ventnculirr trabeculac were pooled. Trabeculae from failing hearts were classified in three groups according to the degree of morphological 
alteration determined hy microscopic in\pcction (see [ex[). 
manuscript to allow comparison of these data to the diseased 
heart expression pattern. Northern blots of left and right 
ventricle samples from 13 transplant recipient hearts show 
that mRNAs for all three a isofornis are expressed in 
diseased human heart (fig 1B and C, hearts 4-16). The 
quality of the RNA varied considerably from sample to 
sample. as could be seen on ethidiuni bromide stained check 
gels (data not shown) and from the variability in the 18s 
rRNA signals (that is. heart 9 (LV), heart 14 (RV). and heart 
16 ILV)). 
For each heart. the contribution of each individual a 
isoform to the total a isoform mRNA pool was calculated by 
dividing thc normalised (to 185 rRNA) signal for each 
isofornr by the sum of the normalised signals for all three. 
The inem and standard deviation for left and right ventricle 
normal heart samples ( n  = 6) and diseased heart samples 
(n = 22, four samples were too degraded for quantification) 
were calculated for cornparison purposes. For the normal 
hearts, the results for a 1 ,  a2, and a3 isoform mRNAs were 
48(SD 21 )%. 26( 13)%. and 27( 10)R of the total a isoform 
pool, respectively. For diseased hearts, the results for a 1, a2. 
and a3 mKNAs were 18(6)%, 30(12)%, and 52(12)%. 
respectively. From these results, it appears that in  normal 
heart the a1 mRNA represents about half the pool. whereas 
in diseased heart a3 represents half the pool. However. thesc 
data must be interpreted with caution due to the small sample 
size for the normal hearts as well as the large variability 
between samples. The large variability may reflect heart to 
heart variation. regional variation within one heart. prefer- 
ential degradation of one or more of the isoforms, or a 
combination of these factors. Due to the variable levels of 
degradation, absolute levels of expression between the 
different hearts were not compared. 
IYei/K-ATPme qiiciritifictitiori 
Samples were obtained from various parts of the left and 
right ventricle free wall and from the septum (total 
numbers=77. 20. and 10, respectively; 1-6 samples per 
heart). Their numbers and locations were not predetermined, 
raising the question whether the data were truly repre- 
sentative of the hearts. However, differences between left 
and right ventricles and septum were not statistically 
significant. (This is in agreement with animal studies.") 
Furthermore, the within heart variation did not affect the 
conclusions regarding the effect of disease on Na/K-ATPase. 
Therefore for the sake of simplicity mean values were 
calculated from the different samples. reducing the data to 
one observation per heart. Expressed per g wet weight, 
[ 'Hlouabain binding decreased from 507(48) pmol in non- 
failing to 293(74) in failing hearts (-42%, p<<0.001). The 
disparity was not related to age, which ranged from 1.5 to 
60 years (table 11). Although a steep decrease in ouabain 
binding during the first six months of life has been reported, 
we did not test infant hearts." When hearts were grouped 
according to aetiology, an analysis of variance showed that 
the variability was dependent on the type of cardiomyopathy 
(p=0.006). Table I11 shows that the effect of disease was 
also highly significant when binding data were expressed per 
tissue dry weight, DNA, myosin, or total protein, instead of 
tissue wet weight. Thus we could reasonably exclude the 
involvement of tissue swelling or necrosis in this effect. Na/ 
K-ATPase activity correlated closely with l'H]ouabain 
Table II  
IYO" Dicig Age Se.r CO LVEF RAP PAP OBG 
Clinical data for the hearts used in biochemical study. 
- 
3 
1 
15 
7' 
9 
10 
5 
16" 
13 
8 
1" 
I I  
12" 
6 
14- 
7 - 
- 
NE 2 M NA NA NA 
NF 15 F NA NA NA 
NF 27 M NA NA NA 
NF 39 F NA NA NA 
NF 60 F NA NA NA 
IS 41 M 5 7  14 2 
IS 48 M 6.0 13 12 
IS 52 M 3.4 16 7 
1s 54 M 4.1 17 8 
IS 58 M 3.5 9 18 
ID 34 M 6.8 16 3 
ID 38 M 2 9  23 NA 
ID 47 M 3 7  20 10 
D 44 M NA 20 12 
DID 20 M 4.4 15 6 
DID 54 F 2.8 17 10 
H 32 M 3.9 21 8 
HT 39 M 2.7 7 20 
NA 
NA 
NA 
NA 
NA 
25 
42 
35 
27 
36 
26 
42 
35 
45 
31 
36 
31 
50 
526 
511 
446 
572 
478 
301 
260 
184 
308 
290 
320 
330 
358 
289 
217 
222 
477 
246 
" refers to heart numbers used in fig I .  
v Indicates previous digitalis therapy. 
CO = cardiac output (litres.min-I); LVEF = left ventricular ejection fraction 
(%): RAP = right atrial pressurc (mm Hg); PAP = pulmonary artery pressure 
(inm Hg): OBG = ['Hlouabain binding (pmo1.g-l wet weight); NA =no 
available data: DIAG = cardiomyopathy type; NF  = non-failing; IS = isch- 
aemic; ID = idiopathic; D =dilated: DID = dilated idiopathic; H =hyper- 
trophic: HT = hypertensive. 
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Table 111 NdK-ATPase activity and other biochemical variables in human heart samples. Values are mean(SD), except those indicated 
by an asterisk, which are median (IQR). 
Non-failing hearts Failing heurts P Decrrcw 
(n  = 5) (n = 13) f%J 
Tissue dry weight (mg,g-l w wt) 25 l(37) 255(33) 0.83 
DNA (mg,g-l w wt) 2.32(0.64) 2.03(0.17) 0.13 12 
Protein (mg.g-' w wt) 119(5) 106(13) 0.05 1 1  
Myosin (mg.g-' w wt) 19.7(4.8) 17.9(3.8) 0.41 9 
Creatine phosphokinase ( I U g I )  
per g dwt 2.93(0.85) 
per g w wt 722( 177) 
per mg DNA, 338(130) 
per mg protein 6.1 (1.7) 
per mg myosin 37(6) 
per g dwt 12.4(2.0) 
per g w wt* 3.06(0.33) 
per mg DNA I .41(0.40) 
per mg myosin* 0.156(0.025) 
per g dwt 2050(320) 
per g w wt 507(48) 
per mg DNA, 232(61) 
per mp protein 4.37(0.66) 
per mg myosin 26.5(4.5) 
NdK-ATPase activity ( p o l  Pi.min-l) 
per mg protein* 0.0252(0.0021) 
['HIOuabain binding B,,, (pmol) 
Turnover rate (s-') 121(7) 
2.05(0.33) 
550( 122) 
274(65) 
5.3( 1.4) 
33(12) 
0.009 
0.03 
0.18 
0.30 
0.44 
6.6(1.9) <<O.OOl 
1.64(0.37) <<0.001 
0.84(0.26) 0.003 
0.0149(0.0037) 0.002 
O.OSS(0.033) 0.006 
30 
24 
19 
13 
1 1  
47 
46 
40 
41 
44 
1140(270) <<O.OOl 44 
293(74) <<0.001 42 
146(37) 0.002 37 
2.79(0.80) 0.001 36 
17.2(6.5) 0.01 35 
117(19) 0.54 3 
NdK-ATPase activity was determined at 150 mM Na+ and 20 nM K'. 
Turnover rate = NdK-ATPase activity/['H]ouabain B,,,; w wt = tissue sample 
binding (fig 2), indicating that the apparent concentration of 
NdK-ATPase was altered by disease, but not its molecular 
turnover rate. For comparison, creatine kinase activities are 
also reported in table 111. A statistically significant decrease 
of this enzyme was observed in failing hearts only when 
tissue wet or dry weight was used as reference. 
Potential inte ference from digoxin therapy 
In hearts from patients previously treated with digoxin, the 
drug may have remained bound to NdK-ATPase and 
interfered with the determinations. To check for such inter- 
ference, we measured 1 IJ.M [3H]ouabain binding at two 
incubation times: 5 min (sufficient for complete saturation of 
NdK-ATPase with [3H]ouabain) and 4 h (sufficient for 
virtually complete dissociation of digoxin binding). Thus if 
4r ,*D; 
P, 
I I I 
200 400 600 
pmol [3H]-ouabaing' wet weight 
Figure 2 Relation between NdK-ATPase activity (vertical axis) 
and [3H]ouabain binding in non-failing (jilled squares), ischaemic 
(circles), idiopathic (triangles), idiopathic-dilated (inverted 
triangles), hypertensive (diamond), hypertrophic (*), and dilated 
(i) human hearts. NdK-ATPase activity was determined at 150 
mM Na' and 20 mM K'. The symbols represent individual hearts. 
The dotted lines represent 95% conjidence limits. 
wet weight; dwt = dry weight. 
digoxin was bound to NdK-ATPase, [3H]ouabain binding 
should have increased after the longer incubation. We 
observed no difference between the binding data after 5 min 
and 4 h in any of the 18 hearts used in this study, irrespective 
of whether digoxin had been prescribed before surgery (data 
not shown). 
We further checked whether digoxin could have been 
released from NdK-ATPase during the membrane prepar- 
ation as a result of homogenisation in hypotonic buffer, 
ultracentrifugation, and/or treatment of the homogenate with 
detergent. To estimate this effect, control homogenates were 
incubated with 1 pM digoxin for 5 min in the presence of 
MgC1, and inorganic phosphate (Pi) (this is sufficient for 
complete saturation of NdK-ATPase with digoxin), sub- 
mitted to ultracentrifugation, and treated with DOC exactly 
as described in Methods. These homogenates were then 
challenged with 1 pM C3H]ouabain for 5 min. Digoxin 
pretreatment inhibited 60% of the specific ['Hlouabain 
binding, indicating that DOC treatment results in the release 
of 40% of the bound digoxin. After a 4 h incubation, digoxin 
pretreatment had no effect on [3H]ouabain binding, indi- 
cating complete release of the drug. Thus in samples from 
digoxin treated patients part of the specifically bound 
digoxin gets washed out during sample preparation. 
Kinetics of NdK-ATPase activation and ["Hlouabain 
binding 
No significant difference was observed in enzyme and 
binding kinetics in left ventricle, right ventricle, and septum; 
therefore, mean values were calculated for each heart. 
Figure 3 illustrates the activation of NdK-ATPase by Na' 
and K' and its inhibition by dihydro-ouabain and vanadate. 
V,,, decreased from 3.6(0.5) pmol Pi.g-' wet weight.min-' 
in non-failing hearts to 2.0(0.4) in failing hearts (p<<O.OOl), 
while activation and inhibition constants and Hill 
coefficients did not change. The Na' and K' sensitivities and 
the molecular turnover rate of NdK-ATPase agree well with 
data from purified preparations,''-l4 23 showing that DOC 
treated homogenates are suitable for NdK-ATPase 
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loon 50 
characterisation. It is interesting to note that a isoforms have 
different Na- ensitii4ies." 
Figure 3 shows dissociation kinetics of the NdK-ATPase- 
['W]ouabain complex. As previously reported, dissociation 
kinetics can be fitted to a two site model in human heart 
membranes" and to a one site niodel in kidney." This tissue 
difference cat1 be accounted for by different isoenzyme 
compositions. The slow complex represented 4 9 9  and 52% 
of the specific sites. respectively, in non-failing (k, = 
0.047.min ': k, = 0.009.niin-I) and failing hearts (k ,  = 
0.052.min-': k,  = 0.01 I .min I). It is clear that a third high 
affinity site indistinguishable from the other two niay be 
present. as suggested by the mRNA analysis, and that makes 
the identification of the binding sites uncertain. 
Discussion 
Our initial studies showed that failing human hearts contain 
trabeculae that are more sensitive to the inotropic and toxic 
effects of ouabain. and we examined various hypotheses that 
could account for the difference. An original feature of this 
study was that the fibres were inspected under the light 
microscope after the contractility experiments. Thus. 
although nccrotic fibres were discarded, the experiments 
were not designed to look at the "best case" response to 
inotropic stimulation. We found two types of fibres in 
diseased hearts: apparently normal fibres and fibres showing 
morphological alterations characteristic of diseased heart. 
Only visibly damaged fibres showed functional changes: ( I  ) 
reduced maximum effect of ouabain, and ( 2 )  inotropic and 
toxic response\ at markedly lower concentrations of ouabain. 
The fact that the inotropic responses to calcium and ouabain 
were similarly reduced suggests that this reduction may be 
related to losil of contractile material andor  to reduced 
rnyofibrillar ATPase activity.'6 I t  is crucial to note that the 
inotropic efkct of ouabain was concentration dependent in 
nowfailing tibres. in  agreement with animal studies." The 
unexplained all or nothing inotropic response of non-failing 
human papillary muscle in a previous study' did not allow 
a valid comparison with failing hearts. Thus the present 
study s h o w  conclusively. and for the first time. an increased 
sensitivity of tailing human fibres to digitalis. 
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Figure 4 Dissociation kiiietics of the Na/K-ATPa,se-[-~H]ouabaiii 
corrip1e.u in riorz-j~ii l ing (ti = 5. m p t y  triangles) ciridjailitig (11 = 13, 
,filled triatigles) hirinaii hearts. Error bars = SEM. Dotted lines 
represetit the coriipirred jicncrions fo r  two sites. Inset: Comparison 
betnwri hrrnzr1ri  heart (filled triangles) mid human kidney 
(sql/(lres). 
To explain this observation, we first hypothesised that 
failing hearts might express a higher affinity isoform of the 
NdK-ATPase. Indeed, three a isoforms with varying 
affinities for cardiac glycosides have been observed in 
mammalian tissues." For example, the affinity of CY 1 
expressed in the kidney varies greatly among species,25 
ranging from the human a l ,  which is one of the most 
sensitive to ouabain (1 nM), to the rat a], which is highly 
resistant (10 pM). In the rat,'x the affinities for a2 and a3 
are respectively 100 and 1000 times more sensitive than the 
affinity for a 1. In other species, the affinities for a2 and a3 
are less precisely known, but analysis of inhibition and 
binding kineti& in tissues predominantly expressing these 
isoforms suggests high affinities similar to those for rat a2 
and a3. In human heart membranes, the dissociation kinetics 
of the ['Hlouabain enzyme complex show a complex pattern 
that is compatible with the presence of different isoforms, in 
agreement with niRNA analysis. The slower phase (higher 
affinity) is close to the monophasic dissociation observed in 
human kidney. suggesting that it may represent a l .  Thus, 
although this deduction still has to be verified 
experimentally,' it appears that human a1 could be 5 to 10 
times more sensitive to ouabain than human a2 and a3; 
therefore an increase in a1 expression could augment the 
ouabain sensitivity of failing human hearts. 
In this study, we have confirmed previous reports that the 
three a isoform mRNAs are expressed in both failing' and 
non-failing hearts.' ' When we quantified the mRNA levels 
for each a isoform the errors were quite large. The a 1, a.2, 
and a3 mRNAs comprised 48(SD 21)%, 26(13)%, and 
27(10)%, respectively, of the total a isoform pool in normal 
hearts, and 18(6)%, 30( 12)%, and 52( 12)%, respectively, in 
diseased hearts. Due to the large variability in the isoform 
levels. we are not certain that the apparent shift towards less 
a1 and more a3 in disease is significant. Our results, 
including the large variability, are similar to those published 
by Allen el al,' who report a 1:0.3:0.5 ratio for al:a2:a3 
mRNA expression in both normal and diseased heart. Their 
variability, when converted from SEM to SD, is similar to 
ours. Although the large variability in  mRNA levels of each 
isoform may reflect heart to heart variation or regional 
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variation within one heart, it may also be caused by selective 
degradation of one or more isoforms. The degradation level 
from sample to sample varied considerably, as evidenced by 
a 20-fold range in 18s rRNA levels per 10 kg of total RNA. 
In fact, we were surprised at the variability that Allen et a17 
observed in the a 1, a2, and a3 mRNA levels, because their 
evaluation was done from slot blots instead of northern blots, 
and their samples were stored in liquid nitrogen instead of 
at -70°C. Since we used northern blots, we considered our 
results to be semiquantitative, especially for the a2 mRNAs 
which run at 5.7 and 6.1 kb6; the signals tend to be slightly 
smeared by the 28s rRNA band and may not transfer as 
efficiently as mRNAs that do not run with the rRNAs. 
Moreover, in our hands, the RNA from heart samples stored 
at -70°C tended to be more degraded than that from samples 
stored in liquid nitrogen (data not shown). We were also 
concerned about the specificity of the probes used, since they 
came from rat cDNAs, which are not identical to human 
sequences; the regions the probes are derived from were not 
specified and the primary data used to determine probe 
specificity were not shown or referenced. For our study, we 
used 60mer oligonucleotides derived from published human 
sequences, which we had previously shown to be isoform 
specific using northem analysk6 
As it is not known whether the correlation between mRNA 
and the expressed protein is maintained in diseased hearts, 
we have attempted to study the NdK-ATPase isoforms at the 
protein level by analysing the dissociation kinetics of the 
['Hlouabain enzyme complex (a technique much more 
sensitive than Scatchard analysis to distinguish between 
forms with similar binding site affinities7 1 4 ) .  The complex 
pattern of dissociation kinetics is not changed in failing 
hearts. Therefore there is no evidence for any change in 
isoform expression at the protein level that could account for 
the increased digitalis sensitivity. 
We then hypothesised that failing hearts may have a lower 
NdK pump reserve capacity resulting from a decrease in Na/ 
K-ATPase density such that less inhibition is required to 
produce pharmacological responses. Previous studies on 
['Hlouabain binding site concentration in failing hearts have 
led to contradictory conclusions, for example that both 
significant and non-significant decreases can O C C U ~ . ~  3634 36 
Figure 5 shows that these studies are not contradictory from 
a statistical ~ t andpo in t ,~~  since decreases between 26% and 
32% fall within the confidence intervals. However, there are 
important methodological differences. In one group of 
studies (A to E, inclusive), small samples of tissue were 
frozen, thawed, and incubated for hours in the presence of 
['Hlouabain, and binding data were expressed per g wet 
weight. In studies A,30 B,3' C,32 and D33 it was concluded 
there were significant decreases in N d K  pumps in failing 
hearts, while study E34 showed no significant decrease. It is 
uncertain whether this discrepancy is due to the use of 
explants in study E instead of biopsies or of Fab fragments 
to eliminate bound digoxin resulting from previous therapy, 
or to insufficient statistical power (large variability and small 
number of hearts). This uncertainty is compounded by the 
failure of other reports, independent of the water content of 
the samples, to express binding data. The potential drawback 
of using small (a few mg) samples has been briefly discussed 
by this group in an earlier study on necropsy samples,35 but 
verification of the water content was not reported in A to E. 
In another group of studies indicating that there are non- 
significant decreases in binding sites (G36 and H4), large 
pieces of tissue were used (several grams), but ['Hlouabain 
binding was measured in a membrane fraction instead of in 
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Figure 5 Comparison between [jH]ouabain binding data from 
this and from previous studies (for references see text). Conjidence 
intervals of the differences between non-failing and ,failing groups 
were calculated according to Gardner and Altnianz9 by using the 
means, SEM, and numbers of hearts reported. Note that this 
comparison is  valid in so far as methods are comparable and 
random sampling applied. Data have been normalised and 
expressed as percent of the means of the nomfailing groups. 
Ejection fraction was not determined fo r  nonyailing hearts in 
studies E to H and is assumed to be normal (about 60%). 
Diagnoses were dilated (A, C1, D, G, and H) ,  idiopathic dilated 
(B), and ischaemic (C2, E )  cardiomyopathies. Methodological 
differences between studies are indicated in the jigure. Studies A to 
D: biopsies were obtained from cardiac patients divided among 
groups according to their ejection fractions: many patients were 
treated with digitalis in failing and nomfailing groups; the total 
concentration of specijic sites was determined in intact 
endocardium and corrected for methodological errors. Study E: 
tiny pieces of myocardium were obtained from explanted hearts 
( "explants "); methodology as in preceding studies except that 
tissue was washed with digoxin Fob prior to binding assay. Study 
F: present study. Studies G and H: ouabain binding was measured 
to a membrane fraction isolated from lefi veniricular (LV) or right 
auricular (RA) myocardium of explanted hearts; failing patients 
were treated with digitalis in G, but not in H. 
whole tissue extracts and expressed per mg of membrane 
protein. The possibility of NdK-ATPase redistribution 
between membrane fractions was not examined. In the 
present study, we took care to check or minimise the 
influence of such pitfalls by using large samples, ensuring 
complete recovery of NdK-ATPase, using different 
references to express data, and checking that interference of 
bound digoxin was negligible. We further examined the 
maximum turnover rate or the sodium sensitivity of Nd 
K-ATPase, which might be affected by changes in the lipid 
composition of the sarcolemma, or by the action of 
proteases. We did not find any change in these important 
variables and, although we did not examine the ATP binding 
site directly, the vanadate or phosphate binding site was not 
altered. Our results suggest a mean 42% decrease of the 
enzyme concentration in failing hearts (ranging from 26% to 
56%). as opposed to a change in isozynie composition, or 
some other alteration in its properties. 
Is such a decrease sufficient to account for the increased 
digitalis sensitivity? Schmidt rt cr17' have estimated that the 
occupation of digitalis receptors by disoxin is about 24% in 
digitalised patients. In animal studies. 50-6552 inhibition of 
NdK-ATPase has been estimated to produce arrhythmias 
with digitalis glycosides." .I8 I t  is clear that less glycoside 
may be required to produce inotropic and toxic effects if the 
NdK-ATPase concentration decreases by 26-56%. However, 
because of limitations inherent in this study. additional proof 
would be needed to establish a link between NdK-ATPase 
concentration and inotropic responsiveness in failing human 
hearts. Ouabain binding data represent apparent Na/ 
K-ATPace concentrations. not actual densities. since changes 
in myocytt: number. shape, and size werc not taken into 
account. Our data were from relatively large samples and 
showed little \,ariation across the ventricles. in agreement 
uith a previous study using necropsj samples." but in 
contrast with the results of contractility experiments in which 
trabeculae from a failing heart differed markedly in their 
inotropic responses. Furthermore. a single (hypertrophic) 
failing heart showed normal NdK-ATPase acti\,ity. 
Therelore it is unlikely that a decrease in NdK-ATPase 
[ilonr explains the increased digitalis sensitivity. Changes 
distal to  Na/K-ATPase affecting. for example. sodium 
permeability. NdCa exchange. or ATP content may also be 
i n volved . 
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